Table 4.
Mean WTP in SEK per month (SD) for microtablets and electronic dispenser, of all patients and L/e patients in situations 1, 2, and 3, respectively
| Situation 1 (administration)
|
Situation 2 (administration and side effects)
|
Situation 3 (administration, side effects, and better effect)
|
||||
|---|---|---|---|---|---|---|
| n | WTP | n | WTP | n | WTP | |
| All respondents | ||||||
| Definitely sure | 159 | 440 (560) | 166 | 490 (612) | 208 | 661 (1,065) |
| Probably sure | 192 | 419 (591) | 189 | 414 (574) | 209 | 532 (702) |
| Total | 688 | 230 (468) | 662 | 252 (491) | 660 | 396 (780) |
| Using entacapone, L/e | ||||||
| Definitely sure | 140 | 296 (464) | 142 | 370 (549) | 158 | 546 (742) |
| Probably sure | 134 | 339 (659) | 125 | 343 (639) | 131 | 541 (816) |
| Total | 298 | 226 (505) | 293 | 256 (530) | 293 | 436 (764) |
Abbreviations: WTP, willingness to pay; SD, standard deviation; L/e, levodopa/entacapone.